Mesenchymal stem cells to treat type 1 diabetes.
Mesenchymal stem cells
Stem cells
Type 1 diabetes
Journal
Biochimica et biophysica acta. Molecular basis of disease
ISSN: 1879-260X
Titre abrégé: Biochim Biophys Acta Mol Basis Dis
Pays: Netherlands
ID NLM: 101731730
Informations de publication
Date de publication:
01 04 2020
01 04 2020
Historique:
received:
05
07
2018
accepted:
26
10
2018
pubmed:
7
12
2018
medline:
4
8
2020
entrez:
4
12
2018
Statut:
ppublish
Résumé
What is clear is we are in the era of the stem cell and its potential in ameliorating human disease. Our perspective is generated from an in vivo model in a large animal that offers significant advantages (complete transplantation tolerance, large size and long life span). This review is an effort to meld our preclinical observations with others for the reader and to outline potential avenues to improve the present outlook for patients with diabetes. This effort exams the history or background of stem cell research in the laboratory and the clinic, types of stem cells, pluripotency or lack thereof based on a variety of pre-clinical investigations attempting endocrine pancreas recovery using stem cell transplantation. The focus is on the use of hematopoietic and mesenchymal stem cells. This review will also examine recent clinical experience following stem cell transplantation in patients with type 1 diabetes.
Identifiants
pubmed: 30508575
pii: S0925-4439(18)30436-8
doi: 10.1016/j.bbadis.2018.10.033
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
165315Informations de copyright
Copyright © 2018 Elsevier B.V. All rights reserved.